JP2010522181A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010522181A5 JP2010522181A5 JP2009554622A JP2009554622A JP2010522181A5 JP 2010522181 A5 JP2010522181 A5 JP 2010522181A5 JP 2009554622 A JP2009554622 A JP 2009554622A JP 2009554622 A JP2009554622 A JP 2009554622A JP 2010522181 A5 JP2010522181 A5 JP 2010522181A5
- Authority
- JP
- Japan
- Prior art keywords
- halogen
- alkyl
- hydroxy
- aryl
- absent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89601407P | 2007-03-21 | 2007-03-21 | |
| PCT/US2008/055084 WO2008115671A1 (en) | 2007-03-21 | 2008-02-27 | Method for treating cb2 receptor mediated pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010522181A JP2010522181A (ja) | 2010-07-01 |
| JP2010522181A5 true JP2010522181A5 (enExample) | 2011-03-31 |
Family
ID=39766329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009554622A Withdrawn JP2010522181A (ja) | 2007-03-21 | 2008-02-27 | Ｃｂ２受容体介在疼痛を処置する方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080234347A1 (enExample) |
| EP (1) | EP2139326A4 (enExample) |
| JP (1) | JP2010522181A (enExample) |
| KR (1) | KR20090120499A (enExample) |
| CN (1) | CN101677556A (enExample) |
| AR (1) | AR065800A1 (enExample) |
| AU (1) | AU2008229264A1 (enExample) |
| CA (1) | CA2681381A1 (enExample) |
| CL (1) | CL2008000827A1 (enExample) |
| MX (1) | MX2009010162A (enExample) |
| PE (1) | PE20090062A1 (enExample) |
| TW (1) | TW200901972A (enExample) |
| UY (1) | UY30973A1 (enExample) |
| WO (1) | WO2008115671A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010088050A2 (en) * | 2009-01-28 | 2010-08-05 | Cara Therapeutics, Inc. | Bicyclic pyrazolo-heterocycles |
| KR20200088765A (ko) * | 2017-11-15 | 2020-07-23 | 파낙 파마 인코퍼레이티드 | 간질성 방광염의 치료 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2005063241A1 (ja) * | 2003-12-26 | 2007-07-19 | 小野薬品工業株式会社 | ミトコンドリアベンゾジアゼピン受容体介在性疾患の予防および／または治療剤 |
| EP1735286B1 (en) * | 2004-03-24 | 2012-01-04 | Janssen Pharmaceutica NV | Tetrahydro-indazole cannabinoid modulators |
| FR2875230A1 (fr) * | 2004-09-13 | 2006-03-17 | Sanofi Aventis Sa | Derives de pyrazole condense, leur preparation et leur application en therapeutique |
| US8378117B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
| BRPI0616402A2 (pt) * | 2005-09-23 | 2011-06-21 | Janssen Pharmaceutica Nv | moduladores de canabinóide de hexaidro-cicloeptapirazol |
-
2008
- 2008-02-27 CN CN200880016433A patent/CN101677556A/zh active Pending
- 2008-02-27 JP JP2009554622A patent/JP2010522181A/ja not_active Withdrawn
- 2008-02-27 EP EP08730816A patent/EP2139326A4/en not_active Withdrawn
- 2008-02-27 AU AU2008229264A patent/AU2008229264A1/en not_active Abandoned
- 2008-02-27 WO PCT/US2008/055084 patent/WO2008115671A1/en not_active Ceased
- 2008-02-27 CA CA002681381A patent/CA2681381A1/en not_active Abandoned
- 2008-02-27 MX MX2009010162A patent/MX2009010162A/es unknown
- 2008-02-27 US US12/038,029 patent/US20080234347A1/en not_active Abandoned
- 2008-02-27 KR KR1020097020429A patent/KR20090120499A/ko not_active Withdrawn
- 2008-03-19 PE PE2008000513A patent/PE20090062A1/es not_active Application Discontinuation
- 2008-03-19 UY UY30973A patent/UY30973A1/es unknown
- 2008-03-19 AR ARP080101149A patent/AR065800A1/es not_active Application Discontinuation
- 2008-03-20 TW TW097109756A patent/TW200901972A/zh unknown
- 2008-03-20 CL CL200800827A patent/CL2008000827A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5966014B2 (ja) | 新規トリフルオロメチル−オキサジアゾール誘導体および疾患の処置におけるその使用 | |
| JP2022071010A (ja) | アルギナーゼ活性を阻害する組成物及び方法 | |
| CN105120866B (zh) | 与毒性醛相关的疾病和治疗 | |
| CN109970708B (zh) | 大麻素受体调节剂 | |
| US9518044B2 (en) | Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto | |
| RU2707752C2 (ru) | Композиции, включающие трамадол и целекоксиб, для лечения боли | |
| CN112424174A (zh) | 可用于治疗疾病的杂环化合物 | |
| JP5786034B2 (ja) | 脂質異常症の治療に適したヘテロ環式化合物 | |
| JP2012514655A (ja) | フッ素含有化合物およびその使用法 | |
| JP2010510202A5 (enExample) | ||
| JP2018534286A5 (enExample) | ||
| TW200942239A (en) | Phenylacetamide derivatives | |
| US8729073B2 (en) | 5-methyl-1-(naphthalen-2-yl)-1H-pyrazole derivatives and their use in potentiating the effect of opioid analgesics | |
| JP2010522710A5 (enExample) | ||
| JP2014532730A5 (ja) | オピオイド受容体の調節物質およびそれを含む薬学的組成物 | |
| JP2013525356A5 (enExample) | ||
| JP2019501948A (ja) | 化学療法で誘導される末梢神経障害の治療に使用するためのｉｌ−８阻害剤 | |
| CN104902893B (zh) | 盐皮质激素受体拮抗剂 | |
| JP2010522181A5 (enExample) | ||
| JP7247106B2 (ja) | 内臓痛の治療のための化合物および方法 | |
| JP2010522182A5 (enExample) | ||
| US10533012B2 (en) | (R)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| TW200804317A (en) | Heterocycle-substituted 3-alkyl azetidine derivatives | |
| JP7497400B2 (ja) | Ｇｐｒ６のテトラヒドロピリドピラジンモジュレーター | |
| JP2013532146A5 (enExample) |